Top Markets
Coin of the day
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc.

STSA
Rangering i aksjer #29898
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative therapies for the rapid relief of migraines. Its lead therapeutic candidate, STS101, is an integrated drug-device system comprising a proprietary dry-powder formulation of dihydroergotamine mesylate. Currently, STS101 is progressing through its pivotal SUMMIT Phase 3 efficacy trials and is designed for self-administration via a specialized, pre-filled, single-use nasal delivery device. Established in 2016, the company maintains its headquarters in South San Francisco, California.
Aksjekurs
$1.10
Sist synkronisert: 2023-06-07
Markedsverdi
$19.12M
Endring (1 dag)
-0.90%
Endring (1 år)
0.00%
Land
US
Handel Satsuma Pharmaceuticals, Inc. (STSA)

Kategori

Pris STSA pris med markedsverdi på B
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
STSA
$1.10
Markedsverdi av Satsuma Pharmaceuticals, Inc.(STSA)
Markedsverdi: $19.12M
Per August 2026 har Satsuma Pharmaceuticals, Inc. en markedsverdi på $19.12M. Dette gjør Satsuma Pharmaceuticals, Inc. til det 29898th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Satsuma Pharmaceuticals, Inc. fra 2019 til 2026
STSA sammenlignet med topp 5 mest populære stocks
Pris på STSA Eiendel B Markedsverdi for B Resultater
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$305,274 $19.12M
$5.307T +27,752,060.77%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$261,792 $19.12M
$4.551T +23,799,151.07%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$238,990 $19.12M
$4.154T +21,726,238.19%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$206,440 $19.12M
$3.589T +18,767,150.37%
Satsuma Pharmaceuticals, Inc. Satsuma Pharmaceuticals, Inc.
$160,895 $19.12M
$2.797T +14,626,747.68%